View Older Stories

Feb 24, 2026 07:30AM Keenova Unveils Clinical Data from Phase 2 Plantar Fibromatosis Study at the ACFAS Annual Meeting

Feb 16, 2026 07:30AM Keenova Announces New Manuscript on Plantar Fibromatosis Treatment Patterns in Peer-Reviewed Journal of Foot and Ankle Surgery

Jan 21, 2026 07:30AM Keenova Marks 100K Peyronie's Disease Patients--a Major Milestone for an Often-Stigmatized Men's Health Condition

Jan 13, 2026 04:47PM Keenova presents Dupuytren's contracture survey at hand surgery meeting

Jan 13, 2026 04:45PM Keenova Announces New Dupuytren's Contracture Survey Presentation About Patient Perceptions and Treatment Outcomes

Nov 10, 2025 07:00AM Mallinckrodt Reports Third Quarter 2025 Financial Results

Nov 10, 2025 06:30AM Mallinckrodt completes Par Health spin-off, rebrands as Keenova Therapeutics

Nov 10, 2025 06:30AM Mallinckrodt Completes Spin-Off of Par Health, Introduces Keenova Therapeutics

Oct 31, 2025 08:00AM Mallinckrodt to Present Data on Terlipressin at the 2025 American Association for the Study of Liver Diseases (AASLD) Annual Meeting

Sep 18, 2025 06:45AM Mallinckrodt publishes Acthar Gel arthritis treatment study results

Sep 18, 2025 06:45AM Mallinckrodt Announces Publication of Findings on Treatment Patterns and Outcomes in Patients with Two Types of Arthritis Treated with Acthar® Gel (repository corticotropin injection)

Aug 6, 2025 06:30AM Mallinckrodt plc Reports Financial Results for Second Quarter 2025 and Provides Guidance

Aug 1, 2025 07:00AM Mallinckrodt completes merger with Endo to form combined therapeutics company

Aug 1, 2025 07:00AM Mallinckrodt, Endo Complete Merger to Create Global, Scaled, Diversified Therapeutics Leader

Jun 18, 2025 06:48AM Mallinckrodt Announces Publication of Real-World Insights on Patient Experience with Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect™ Injector

Jun 9, 2025 08:33AM Mallinckrodt (MNK) and Endo (NDOI) Announce Planned Leadership Team for Merged Company

Jun 9, 2025 08:30AM Mallinckrodt, Endo Announce Planned Leadership Team for Merged Company

May 14, 2025 06:52AM Mallinckrodt Presents Data on Real-World Outcomes with Acthar® Gel (repository corticotropin injection) at the International Congress on Systemic Lupus Erythematosus (LUPUS 2025)

May 13, 2025 08:00AM Mallinckrodt and Endo Announce Significant Progress in Proposed Merger

May 6, 2025 06:45AM Mallinckrodt plc Reports First Quarter 2025 Financial Results and Reaffirms Full-Year Guidance

Apr 23, 2025 06:52AM Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection at the 2025 Digestive Disease Week (DDW) Annual Meeting

Mar 13, 2025 06:31AM Mallinckrodt (MNK) and Endo (NDOI) to Combine

Mar 13, 2025 06:31AM Mallinckrodt plc Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides 2025 Guidance

Mar 13, 2025 06:30AM Mallinckrodt and Endo to Combine to Create a Global, Scaled, Diversified Pharmaceuticals Leader

Dec 2, 2024 06:45AM Mallinckrodt Completes Divestiture of Therakos® Business

Nov 18, 2024 11:00AM Mallinckrodt (MNK) Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at the 2024 American Association for the Study of Liver Diseases

Nov 18, 2024 11:00AM Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at the 2024 American Association for the Study of Liver Diseases (AASLD) Annual Meetin

Nov 5, 2024 06:45AM Mallinckrodt plc Reports Third Quarter 2024 Financial Results and Raises Full Year Guidance

Oct 30, 2024 06:50AM Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection at the 2024 American Association for the Study of Liver Diseases (AASLD) Annual Meeting

Oct 29, 2024 08:30AM Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome-Acute Kidney Injury (HRS-AKI) at the American College of Gastroenterology (ACG) Annual Meeti

Oct 26, 2024 01:00PM Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at Kidney Week 2024

Oct 10, 2024 06:52AM Mallinckrodt Announces an Expanded Rollout of the INOmax® EVOLVE™ DS Delivery System in U.S. Hospitals

Sep 17, 2024 06:50AM Mallinckrodt Announces Publication of Human Factors Studies and Arthritis Foundation Ease of Use® Certification of Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect™

Aug 6, 2024 06:45AM Mallinckrodt plc Reports Second Quarter 2024 Financial Results and Raises Full Year Guidance

Aug 6, 2024 06:35AM Mallinckrodt Announces Availability of Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect™ Injector in the U.S.

Aug 5, 2024 07:00AM Mallinckrodt (MNK) to Sell Therakos Business to CVC for $925M

Aug 5, 2024 07:00AM Mallinckrodt Reaches Agreement to Sell Therakos® Business to CVC for $925 Million

Jun 5, 2024 06:45AM Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at the 2024 European Association for the Study of the Liver (EASL) Congress

May 18, 2024 07:00AM Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at the 2024 Digestive Disease Week® (DDW)

May 9, 2024 06:45AM Mallinckrodt plc Reports First Quarter 2024 Financial Results and Reaffirms Full Year Guidance

Mar 26, 2024 04:01PM Mallinckrodt plc Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides 2024 Guidance

Mar 11, 2024 06:52AM Mallinckrodt Announces Journal Publication of Real-World Data on Acthar® Gel (repository corticotropin injection) to Treat Symptomatic Sarcoidosis in African American and Non-African American Patient

Mar 1, 2024 08:50AM Mallinckrodt Announces U.S. FDA Approval of Supplemental New Drug Application for Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect™ Injector

Jan 22, 2024 06:53AM Mallinckrodt (MNK) Presents New Data on TERLIVAZ

Jan 22, 2024 06:52AM Mallinckrodt Presents New Data on TERLIVAZ® (terlipressin) for Injection at the Society of Critical Care Medicine (SCCM) 2024 Critical Care Congress

Nov 15, 2023 07:38AM Mallinckrodt (MNK) Reports its Plan and the Scheme of Arrangement Became Effective, Debtors Emerged from the Chapter 11 Cases

Nov 1, 2023 06:45AM Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the American Society of Nephrology (ASN) Kidney Week 2023 Scientific Meetin

Oct 26, 2023 06:53AM Mallinckrodt (MNKTQ) Presents Latest Health Economics Data on Acthar Gel

Oct 26, 2023 06:53AM Mallinckrodt Presents Latest Health Economics Data on Acthar® Gel (Repository Corticotropin Injection) at the Academy of Managed Care Pharmacy (AMCP) Nexus 2023

Sep 11, 2023 04:33PM Buxton Helmsley Issues Statement on Mallinckrodt plc. Bankruptcy Filing and Disclosures Revealing Apparently Concealed Intangible Asset Depreciation Expenses

View Older Stories